A Centers for Disease Control and Prevention (CDC) committee learned Wednesday of a seventh woman who developed a rare and severe type of blood clot after receiving the J&JCOVID-19 vaccine, and a man whose occurred during clinical trial, but it could not be linked to the jab at the time.
